BioSpace News Archive

Business

Privia Health to Report Fourth Quarter 2021 Results on Friday, March 25

Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2021 before market open on Friday, March 25, 2022.

January 31, 2022
·
1 min read
Business

Replimune Announces the Departure of Dr. Otello Stampacchia from its Board of Directors

Replimune Group Inc. today announced Otello Stampacchia, Ph.D., of Omega Funds, has resigned from the company’s Board of Directors.

January 31, 2022
·
3 min read
Bio NC

Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO Transition

Sio Gene Therapies Inc. today provided a corporate update announcing the prioritization of AXO-AAV-GM1 and AXO-AAV-GM2, its clinical stage AAV gene therapy programs for GM1 and GM2 gangliosidosis (Tay-Sachs/Sandhoff disease).

January 31, 2022
·
8 min read
Deals

Sierra Oncology Announces Closing of Upsized Public Offering of $135.0 Million of Securities

Sierra Oncology, Inc. today announced the closing of its previously announced underwritten public offering of 4,074,075 shares of its common stock at a price to the public of $27.00 per share.

January 31, 2022
·
3 min read
Business

Oxford Biomedica announces update to agreement with Sio Gene Therapies

Oxford Biomedica plc announced today that it was informed on Monday 31 January by Sio Gene Therapies (Sio) that Sio intends to return the global rights for AXO-Lenti-PD and that they intend to cease work on this gene therapy programme in Parkinson’s Disease.

January 31, 2022
·
3 min read
Drug Development

Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate

Valneva SE today announced the initiation of a Phase 3 trial in adolescents for its single-shot chikungunya vaccine candidate, VLA1553.

January 31, 2022
·
10 min read
Business

Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors

Gamida Cell Ltd. today announced the addition of Anat Cohen-Dayag, Ph.D., and Naama Halevi-Davidov, Ph.D., to its Board of Directors as Class II Directors.

January 31, 2022
·
3 min read
Business

Cutera, Inc. to Announce Fourth Quarter and Full-Year 2021 Results on February 22, 2022

Cutera, Inc., a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, announced that it will report financial results for the fourth quarter and full year 2021 after the market close on Tuesday, February 22, 2022.

January 31, 2022
·
1 min read
Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions

Gandeeva Therapeutics, today announced it has raised US$40 million in Series A funding led by Lux Capital and Leaps by Bayer, with participation from Obvious Ventures, Amgen Ventures, Amplitude Ventures and Air Street Capital.

January 31, 2022
·
3 min read
Business

Aytu BioPharma Completes $15 Million Debt Refinancing

Aytu BioPharma, Inc. today announced that it has entered into an agreement with the Avenue Venture Opportunities Fund, L.P., an affiliate of Avenue Capital Group, to refinance the company’s existing senior secured loan facility.

January 31, 2022
·
4 min read